Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Phibro Animal Health
PAHC
$1.37B
| $661K | ﹤0.01% |
25,875
-12,181
| -32% | -$266K |
|
3327
Embecta
EMBC
$290M
| $659K | ﹤0.01% |
68,020
-27,676
| -29% | -$311K |
|
3328
Xerox
XRX
$412M
| $659K | ﹤0.01% |
125,067
-73,470
| -37% | -$358K |
|
3329
Marcus & Millichap
MMI
$1.18B
| $658K | ﹤0.01% |
21,430
-13,377
| -38% | -$406K |
|
3330
Myriad Genetics
MYGN
$309M
| $657K | ﹤0.01% |
123,753
-119,836
| -49% | -$708K |
|
3331
Global X Copper Miners ETF NEW
COPX
$7.97B
| $656K | ﹤0.01% |
14,578
-29,373
| -67% | -$1.17M |
|
3332
ARS Pharmaceuticals
SPRY
$606M
| $656K | ﹤0.01% |
37,583
-57,627
| -61% | -$832K |
|
3333
CRA International
CRAI
$1.07B
| $654K | ﹤0.01% |
3,491
-2,172
| -38% | -$388K |
|
3334
Franklin US Low Volatility High Dividend Index ETF
LVHD
$630M
| $654K | ﹤0.01% |
16,402
-35
| -0.2% | -$1.38K |
|
|
QCMU
3335
Direxion Daily QCOM Bull 2X ETF
QCMU
$22.1M
| $654K | ﹤0.01% |
+25,000
| New | +$642K |
|
|
WSR
3336
DELISTED
Whitestone REIT
WSR
| $652K | ﹤0.01% |
52,283
-29,414
| -36% | -$374K |
|
3337
Teladoc Health
TDOC
$1.26B
| $652K | ﹤0.01% |
74,848
-60,226
| -45% | -$437K |
|
|
CSCL
3338
Direxion Daily CSCO Bull 2X ETF
CSCL
$14.1M
| $652K | ﹤0.01% |
+25,000
| New | +$645K |
|
3339
Sumitomo Mitsui Financial
SMFG
$167B
| $651K | ﹤0.01% |
43,117
-2,481
| -5% | -$35.7K |
|
3340
ProPetro Holding
PUMP
$1.42B
| $651K | ﹤0.01% |
109,119
-21,854
| -17% | -$125K |
|
3341
AdvanSix
ASIX
$427M
| $651K | ﹤0.01% |
27,422
-10,992
| -29% | -$249K |
|
3342
Medifast
MED
$130M
| $651K | ﹤0.01% |
46,327
+38,772
| +513% | +$510K |
|
3343
Chunghwa Telecom
CHT
$32.8B
| $650K | ﹤0.01% |
13,940
+702
| +5% | +$29.9K |
|
3344
Arvinas
ARVN
$580M
| $648K | ﹤0.01% |
88,076
-63,697
| -42% | -$469K |
|
3345
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $648K | ﹤0.01% |
6,505
-4,735
| -42% | -$439K |
|
|
ORC
3346
Orchid Island Capital
ORC
$1.32B
| $648K | ﹤0.01% |
92,427
+14,486
| +19% | +$100K |
|
3347
Ardelyx
ARDX
$1.01B
| $648K | ﹤0.01% |
165,245
-323,595
| -66% | -$1.33M |
|
3348
TransAlta
TAC
$3.92B
| $645K | ﹤0.01% |
59,882
+2,982
| +5% | +$28.4K |
|
|
ELIS
3349
DELISTED
Direxion Shares ETF Trust Direxion Daily LLY Bear 1X ETF
ELIS
| $642K | ﹤0.01% |
25,000
| – | – |
|
3350
iShares MSCI KLD 400 Social ETF
DSI
$5.58B
| $642K | ﹤0.01% |
5,530
+76
| +1% | +$8.09K |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.